Wyoming Chapter of the American College of Cardiology

Join your colleagues from Idaho, Nevada, New Mexico, Utah, and Wyoming on September 6th and 7th for a weekend of hot topics in cardiovascular care including heart failure, amyloid, prevention, clinician wellness, atrial fibrillation, and more! CME/CNE/MOC credits will be provided. We look forward to a wonderful weekend of networking and learning together at the Park City, Utah. For more information and to register, please visit: ACC Rockies Chapter Meeting 2024

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

Latest in Cardiology from ACC.org

ACCEL Lite: Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After PCI
In this episode, Drs. Allen J. Taylor and Joo-Yong Hahn discuss the clinical implications of these findings and offer insights into selecting the optimal single antiplatelet regimen after PCI.
Efficacy and Safety of Catheter Ablation vs. Antiarrhythmic Drugs For Ventricular Tachycardia (VANISH2)
How does the efficacy and safety of catheter ablation as first-line therapy compare with antiarrhythmic drug (AAD) therapy for ventricular tachycardia (VT) in patients with ischemic cardiomyopathy (ICM) and implantable cardioverter-defibrillators (ICDs)?
New ACC Scientific Statement Addresses Management of Obesity in HF
A new ACC Scientific Statement addresses the management of obesity in adults with heart failure (HF), with a specific focus on those with stage 2 HF with preserved ejection fraction (HFpEF).
Sports CV Community Discusses Sleep Apnea, More at the Care of the Athletic Heart Course
Sleep apnea may be more prevalent in younger female athletes, especially among those with higher levels of training, than previously believed, according to research presented at ACC's Care of the Athletic Heart.
Predicting Long-Term Risk of CVD in US Adults With the PREVENT Equations
Most adults in the U.S. have elevated long-term risks of cardiovascular disease based on findings using the PREVENT risk equations, published June 9 in JACC.